Waiting on a rates decision
James Dunn
November 7, 2023
The S&P/ASX 200 (INDEXASX: XJO) closed 19.2 points, or 0.3%,
ResMed Inc (ASX: RMD) is a United States based business that develops and manufactures medical devices to help people with sleep apnea, chronic obstructive pulmonary disease (COPD) and other chronic diseases. ResMed, which is short for Respiratory Medicine, was founded in 1989 by Dr Peter Farrell and now helps customers & patients in over 120 countries.
The S&P/ASX 200 (INDEXASX: XJO) closed 19.2 points, or 0.3%,
Here’s today’s The Match Out report from Market Matters’ James
Here’s today’s The Match Out report from Market Matters’ James
Here’s today’s The Match Out report from Market Matters’ James
After plenty of volatility for the ResMed Inc (ASX:RMD) share
Here are 3 things I wish I knew about life
Will Ozempic sink ResMed Inc (ASX:RMD) and CSL Limited (ASX:CSL)?
The local share market snapped its losing streak, with both
Here’s today’s The Match Out report from Market Matters’ James
Want to level-up your analytical skills and investing insights but don’t know where to start? Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the best insights.
Here you go: A $50,000 per year passive income special report
Join more 50,000 Australian investors who read our weekly investing newsletter and we’ll send you our passive income investing report right now.
Simply enter your email address and we’ll send it to you. No tricks. Unsubscribe anytime.
Unsubscribe anytime. Read our Terms, Financial Services Guide, Privacy Policy. We’ll never sell your email address. Our company is Australian owned.